Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR01000
|
|||||
Drug Name |
Scopolamine
|
|||||
Synonyms |
(-)-Scopolamine hydrobromide trihydrate; 1alphaH,5alphaH-Tropan-3alpha-ol, 6beta,7beta-epo; 1alphaH,5alphaH-Tropan-3alpha-ol, 6beta,7beta-epoxy-, (-)-tropate (ester); 3-Oxa-9-azatricyclo(3.3.1.O(sup 2,4))nonan-7-ol, 9-methyl-, tropate (ester); 9-methyl-3-oxa-9-azatricyclo[3.3.1.0~2,4~]non-7-yl tropate; Atroscine; Atroscine Hydrobromide; Borrachero (TN); Burundanga (TN); Euscopol; Hydroscine hydrobromide; Hyocine F hydrobromide; Hyosceine; Hyoscine (TN); Hyoscine bromide; Hyoscyine hydrobromide; Hysco; Isoscopil; Kwells; L-Hyoscine hydrobromide; Levo-duboisine (TN); MOLI001381; NCI61806; SCOPOLAMINE BROMIDE; SEE; Scop; Scopamin; Scopoderm-TTS; Scopolamine (INN); Scopolamine Hyoscine; Scopolaminhydrobromid; Scopolaminium bromide; Scopolammonium bromide; Scopos; Sereen; Tranaxine; Transcop; Transderm scop (TN); Triptone; Tropane alkaloid; Xy-, (-)-tropate (ester)
|
|||||
Drug Type |
Small molecular drug
|
|||||
Therapeutic Class |
Antispasmodics
|
|||||
Structure |
|
|||||
3D MOL | 2D MOL | |||||
Formula |
C17H21NO4
|
|||||
Canonical SMILES |
CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4
|
|||||
InChI |
InChI=1S/C17H21NO4/c1-18-13-7-11(8-14(18)16-15(13)22-16)21-17(20)12(9-19)10-5-3-2-4-6-10/h2-6,11-16,19H,7-9H2,1H3/t11?,12-,13-,14+,15-,16+/m1/s1/i17+2
|
|||||
InChIKey |
STECJAGHUSJQJN-OHCMNABBSA-N
|
|||||
CAS Number |
CAS 51-34-3
|
|||||
Pharmaceutical Properties | Molecular Weight | 305.34 | Topological Polar Surface Area | 62.3 | ||
Heavy Atom Count | 22 | Rotatable Bond Count | 5 | |||
Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 5 | |||
XLogP |
0.9
|
|||||
PubChem CID | ||||||
ChEBI ID |
ChEBI:16794
|
|||||
TTD Drug ID |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.